| - GRCh37:
- Chr14:20915674
- GRCh38:
- Chr14:20447515
| OSGEP | C292Y | Galloway-Mowat syndrome 3 | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr14:20916144-20916145
- GRCh38:
- Chr14:20447985-20447986
| OSGEP | F238fs | Galloway-Mowat syndrome 3 | Uncertain significance (Jan 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:20916968
- GRCh38:
- Chr14:20448809
| OSGEP | G187V | Galloway-Mowat syndrome 3 | Likely pathogenic (May 14, 2022) | criteria provided, single submitter |
| | OSGEP | G122V | Galloway-Mowat syndrome 3 | Likely pathogenic (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:20916093
- GRCh38:
- Chr14:20447934
| OSGEP | Q255* | Galloway-Mowat syndrome 3, not provided | Uncertain significance (Aug 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:20917130
- GRCh38:
- Chr14:20448971
| OSGEP | A184T | Galloway-Mowat syndrome 3 | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr14:20915804
- GRCh38:
- Chr14:20447645
| OSGEP | R280L | Galloway-Mowat syndrome 3 | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr14:20916272
- GRCh38:
- Chr14:20448113
| OSGEP | S232Y | Galloway-Mowat syndrome 3 | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr14:20920340
- GRCh38:
- Chr14:20452181
| LOC107372315, OSGEP | | not provided, Galloway-Mowat syndrome 3 | Benign (Sep 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:20916987
- GRCh38:
- Chr14:20448828
| OSGEP | | not provided, Galloway-Mowat syndrome 3 | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:20920250
- GRCh38:
- Chr14:20452091
| LOC107372315, OSGEP | | Galloway-Mowat syndrome 3, not provided | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:20916958
- GRCh38:
- Chr14:20448799
| OSGEP | | Galloway-Mowat syndrome 3, not provided | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:20917442
- GRCh38:
- Chr14:20449283
| OSGEP | | Galloway-Mowat syndrome 3, not provided | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:20915802
- GRCh38:
- Chr14:20447643
| OSGEP | G281R | Galloway-Mowat syndrome 3, Inborn genetic diseases | Uncertain significance (Jun 15, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:20920227
- GRCh38:
- Chr14:20452068
| LOC107372315, OSGEP | G106V | Galloway-Mowat syndrome 3 | Uncertain significance (Jul 20, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr14:20917124
- GRCh38:
- Chr14:20448965
| OSGEP | R186* | Galloway-Mowat syndrome 3, not provided | Likely pathogenic (Feb 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:20922762
- GRCh38:
- Chr14:20454603
| LOC107372315, OSGEP | N27K | Galloway-Mowat syndrome 3 | Likely pathogenic (Feb 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr14:20920566
- GRCh38:
- Chr14:20452407
| LOC107372315, OSGEP | I53F | Galloway-Mowat syndrome 3 | Likely pathogenic (Feb 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr14:20915657
- GRCh38:
- Chr14:20447498
| OSGEP | M298L | Galloway-Mowat syndrome 3 | Uncertain significance (Aug 15, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr14:20920225
- GRCh38:
- Chr14:20452066
| OSGEP, LOC107372315 | V107M | Inborn genetic diseases, Galloway-Mowat syndrome 3 | Likely pathogenic (Feb 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:20915434
- GRCh38:
- Chr14:20447275
| OSGEP | R325W | Galloway-Mowat syndrome 3, not provided, Inborn genetic diseases
| Conflicting interpretations of pathogenicity (Aug 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr14:20916116
- GRCh38:
- Chr14:20447957
| OSGEP | R247Q | Galloway-Mowat syndrome 3, not provided | Pathogenic (Sep 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:20915805
- GRCh38:
- Chr14:20447646
| OSGEP | R280C | Galloway-Mowat syndrome 3, Inborn genetic diseases, not provided
| Likely pathogenic (Feb 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:20920212
- GRCh38:
- Chr14:20452053
| LOC107372315, OSGEP | I111T | not provided, Galloway-Mowat syndrome 3 | Pathogenic/Likely pathogenic (Oct 26, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr14:20915804
- GRCh38:
- Chr14:20447645
| OSGEP | R280H | Galloway-Mowat syndrome 3 | Pathogenic (Jun 8, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr14:20922803
- GRCh38:
- Chr14:20454644
| LOC107372315, OSGEP | I14F | not provided | Pathogenic (Oct 23, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr14:20917150
- GRCh38:
- Chr14:20448991
| OSGEP | G177A | not provided | Uncertain significance (Jul 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:20920216
- GRCh38:
- Chr14:20452057
| LOC107372315, OSGEP | C110R | See cases, Galloway-Mowat syndrome 3, not provided
| Pathogenic/Likely pathogenic (Jul 28, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:20915433
- GRCh38:
- Chr14:20447274
| OSGEP | R325Q | Galloway-Mowat syndrome | Pathogenic | criteria provided, single submitter |